Literature DB >> 33603751

Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance.

Jing Chen1, Xu Cao1, Bolei Li1, Zhangchen Zhao2, Siqi Chen1, Seigmund W T Lai1, Sabina A Muend1, Gianna K Nossa1, Lei Wang1, Weihua Guo1, Jian Ye1, Peter P Lee1, Mingye Feng1.   

Abstract

Evasion of immunosurveillance is critical for cancer initiation and development. The expression of "don't eat me" signals protects cancer cells from being phagocytosed by macrophages, and the blockade of such signals demonstrates therapeutic potential by restoring the susceptibility of cancer cells to macrophage-mediated phagocytosis. However, whether additional self-protective mechanisms play a role against macrophage surveillance remains unexplored. Here, we derived a macrophage-resistant cancer model from cells deficient in the expression of CD47, a major "don't eat me" signal, via a macrophage selection assay. Comparative studies performed between the parental and resistant cells identified self-protective traits independent of CD47, which were examined with both pharmacological or genetic approaches in in vitro phagocytosis assays and in vivo tumor models for their roles in protecting against macrophage surveillance. Here we demonstrated that extracellular acidification resulting from glycolysis in cancer cells protected them against macrophage-mediated phagocytosis. The acidic tumor microenvironment resulted in direct inhibition of macrophage phagocytic ability and recruitment of weakly phagocytic macrophages. Targeting V-ATPase which transports excessive protons in cancer cells to acidify extracellular medium elicited a pro-phagocytic microenvironment with an increased ratio of M1-/M2-like macrophage populations, therefore inhibiting tumor development and metastasis. In addition, blockade of extracellular acidification enhanced cell surface exposure of CD71, targeting which by antibodies promoted cancer cell phagocytosis. Our results reveal that extracellular acidification due to the Warburg effect confers immune evasion ability on cancer cells. This previously unrecognized role highlights the components mediating the Warburg effect as potential targets for new immunotherapy harnessing the tumoricidal capabilities of macrophages.
Copyright © 2021 Chen, Cao, Li, Zhao, Chen, Lai, Muend, Nossa, Wang, Guo, Ye, Lee and Feng.

Entities:  

Keywords:  V-ATPase; immunotherapy; macrophage; microenvironment; phagocytosis

Year:  2021        PMID: 33603751      PMCID: PMC7884830          DOI: 10.3389/fimmu.2020.621757

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  82 in total

Review 1.  Macrophages as mediators of tumor immunosurveillance.

Authors:  Siddhartha Jaiswal; Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Trends Immunol       Date:  2010-05-07       Impact factor: 16.687

Review 2.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

Review 3.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

4.  Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.

Authors:  Sharareh Gholamin; Siddhartha S Mitra; Abdullah H Feroze; Jie Liu; Suzana A Kahn; Michael Zhang; Rogelio Esparza; Chase Richard; Vijay Ramaswamy; Marc Remke; Anne K Volkmer; Stephen Willingham; Anitha Ponnuswami; Aaron McCarty; Patricia Lovelace; Theresa A Storm; Simone Schubert; Gregor Hutter; Cyndhavi Narayanan; Pauline Chu; Eric H Raabe; Griffith Harsh; Michael D Taylor; Michelle Monje; Yoon-Jae Cho; Ravi Majeti; Jens P Volkmer; Paul G Fisher; Gerald Grant; Gary K Steinberg; Hannes Vogel; Michael Edwards; Irving L Weissman; Samuel H Cheshier
Journal:  Sci Transl Med       Date:  2017-03-15       Impact factor: 17.956

Review 5.  Programmed cell removal: a new obstacle in the road to developing cancer.

Authors:  Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2011-12-08       Impact factor: 60.716

6.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

Review 7.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

8.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

Review 9.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

Review 10.  Monocarboxylate transporters in cancer.

Authors:  Valéry L Payen; Erica Mina; Vincent F Van Hée; Paolo E Porporato; Pierre Sonveaux
Journal:  Mol Metab       Date:  2019-07-27       Impact factor: 7.422

View more
  5 in total

Review 1.  Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect.

Authors:  Yu-Ling Bin; Hong-Sai Hu; Feng Tian; Zhen-Hua Wen; Mei-Feng Yang; Ben-Hua Wu; Li-Sheng Wang; Jun Yao; De-Feng Li
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

2.  Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer.

Authors:  Zehua Liu; Rongfang Pan; Wenxian Li; Yanjiang Li
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

Review 3.  Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling.

Authors:  Gilnei Bruno da Silva; Milena Ayumi Yamauchi; Daniela Zanini; Margarete Dulce Bagatini
Journal:  Purinergic Signal       Date:  2021-11-05       Impact factor: 3.765

4.  Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy.

Authors:  Xu Cao; Jing Chen; Bolei Li; Jessica Dang; Wencan Zhang; Xiancai Zhong; Chongkai Wang; Mustafa Raoof; Zuoming Sun; Jianhua Yu; Marwan G Fakih; Mingye Feng
Journal:  Sci Adv       Date:  2022-03-18       Impact factor: 14.957

Review 5.  Dual Role of p73 in Cancer Microenvironment and DNA Damage Response.

Authors:  Julian M Rozenberg; Svetlana Zvereva; Alexandra Dalina; Igor Blatov; Ilya Zubarev; Daniil Luppov; Alexander Bessmertnyi; Alexander Romanishin; Lamak Alsoulaiman; Vadim Kumeiko; Alexander Kagansky; Gerry Melino; Nikolai A Barlev
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.